Shandong Polymer Biochemicals Co Ltd (002476) - Total Assets

Latest as of September 2025: CN¥1.13 Billion CNY ≈ $165.76 Million USD

Based on the latest financial reports, Shandong Polymer Biochemicals Co Ltd (002476) holds total assets worth CN¥1.13 Billion CNY (≈ $165.76 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See 002476 book value for net asset value and shareholders' equity analysis.

Shandong Polymer Biochemicals Co Ltd - Total Assets Trend (2007–2024)

This chart illustrates how Shandong Polymer Biochemicals Co Ltd's total assets have evolved over time, based on quarterly financial data.

Shandong Polymer Biochemicals Co Ltd - Asset Composition Analysis

Current Asset Composition (December 2024)

Shandong Polymer Biochemicals Co Ltd's total assets of CN¥1.13 Billion consist of 85.2% current assets and 14.8% non-current assets.

Asset Category Amount (CNY) % of Total Assets
Cash & Equivalents CN¥0.00 41.6%
Accounts Receivable CN¥323.35 Million 30.8%
Inventory CN¥127.08 Million 12.1%
Property, Plant & Equipment CN¥0.00 0.0%
Intangible Assets CN¥8.37 Million 0.8%
Goodwill CN¥0.00 0.0%

Asset Composition Trend (2007–2024)

This chart illustrates how Shandong Polymer Biochemicals Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see 002476 market cap overview.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Shandong Polymer Biochemicals Co Ltd's current assets represent 85.2% of total assets in 2024, an increase from 54.8% in 2007.
  • Cash Position: Cash and equivalents constituted 41.6% of total assets in 2024, up from 4.2% in 2007.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2007.
  • Asset Diversification: The largest asset category is accounts receivable at 30.8% of total assets.

Shandong Polymer Biochemicals Co Ltd Competitors by Total Assets

Key competitors of Shandong Polymer Biochemicals Co Ltd based on total assets are shown below.

Company Country Total Assets
Rongsheng Petrochemical Co Ltd
SHE:002493
China CN¥392.92 Billion
Hoshine Silicon Ind Co Ltd
SHG:603260
China CN¥86.15 Billion
Youngy Co Ltd
SHE:002192
China CN¥4.92 Billion
Guizhou Chanhen Chemical Corp
SHE:002895
China CN¥13.38 Billion
Sinofibers Technology Co Ltd
SHE:300777
China CN¥4.94 Billion
Shaanxi Lighte Optoelectronics Material Co. Ltd. A
SHG:688150
China CN¥2.18 Billion
Hunan Boyun New Materials Co Ltd
SHE:002297
China CN¥3.12 Billion
Solvac S.A.
BR:SOLV
Belgium €2.77 Billion

Shandong Polymer Biochemicals Co Ltd - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 5.68 7.67 5.25
Quick Ratio 4.87 6.12 4.64
Cash Ratio 0.00 0.00 0.00
Working Capital CN¥804.74 Million CN¥658.55 Million CN¥460.46 Million

Shandong Polymer Biochemicals Co Ltd - Advanced Valuation Insights

This section examines the relationship between Shandong Polymer Biochemicals Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 3.98
Latest Market Cap to Assets Ratio 0.50
Asset Growth Rate (YoY) 9.0%
Total Assets CN¥1.05 Billion
Market Capitalization $523.00 Million USD

Valuation Analysis

Below Book Valuation: The market values Shandong Polymer Biochemicals Co Ltd's assets below their book value (0.50x), which may indicate investor concerns about asset quality or future growth.

Positive Asset Growth: Shandong Polymer Biochemicals Co Ltd's assets grew by 9.0% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Shandong Polymer Biochemicals Co Ltd (2007–2024)

The table below shows the annual total assets of Shandong Polymer Biochemicals Co Ltd from 2007 to 2024.

Year Total Assets Change
2024-12-31 CN¥1.05 Billion
≈ $153.78 Million
+9.00%
2023-12-31 CN¥964.15 Million
≈ $141.09 Million
-7.29%
2022-12-31 CN¥1.04 Billion
≈ $152.18 Million
+4.80%
2021-12-31 CN¥992.38 Million
≈ $145.22 Million
-1.75%
2020-12-31 CN¥1.01 Billion
≈ $147.80 Million
+4.64%
2019-12-31 CN¥965.29 Million
≈ $141.25 Million
-8.31%
2018-12-31 CN¥1.05 Billion
≈ $154.05 Million
-17.47%
2017-12-31 CN¥1.28 Billion
≈ $186.67 Million
-12.01%
2016-12-31 CN¥1.45 Billion
≈ $212.16 Million
-6.33%
2015-12-31 CN¥1.55 Billion
≈ $226.50 Million
+13.33%
2014-12-31 CN¥1.37 Billion
≈ $199.87 Million
+22.08%
2013-12-31 CN¥1.12 Billion
≈ $163.72 Million
+6.25%
2012-12-31 CN¥1.05 Billion
≈ $154.08 Million
+6.49%
2011-12-31 CN¥988.84 Million
≈ $144.70 Million
+7.20%
2010-12-31 CN¥922.41 Million
≈ $134.98 Million
+140.75%
2009-12-31 CN¥383.14 Million
≈ $56.06 Million
+1.60%
2008-12-31 CN¥377.09 Million
≈ $55.18 Million
+7.03%
2007-12-31 CN¥352.34 Million
≈ $51.56 Million
--

About Shandong Polymer Biochemicals Co Ltd

SHE:002476 China Chemicals
Market Cap
$523.00 Million
CN¥3.57 Billion CNY
Market Cap Rank
#12315 Global
#3814 in China
Share Price
CN¥5.84
Change (1 day)
-0.51%
52-Week Range
CN¥4.32 - CN¥7.88
All Time High
CN¥12.75
About

Shandong Polymer Biochemicals Co., Ltd., together with its subsidiaries, produces and sells chemicals for oil and gas exploitation in China and internationally. The company offers monomers, surface active agent, and polymers. It also provides oil field stimulation and oil recovery technical services; and environmental protection water treatment products and technical services. The company was fou… Read more